Last time I took a look at Atara Biotherapeutics ( ATRA ), I was intrigued and optimistic about their allogeneic (non-self) CAR T-cell therapy, in a novel indication for engineered cell therapies. But that has been quiteI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfa ...